MedTrace Logo

Unpinning Termination Therapy for VT (US)

NCT03093051 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2022-10-10

No results posted yet for this study

Summary

This observation study evaluates the safety and performance of UPT therapy in subjects during either an indicated ventricular tachycardia ablation procedure or an ICD implant procedure.

Conditions

  • Ventricular Tachycardia

Interventions

DEVICE

Unpinning Termination therapy

Electrotherapy comprised of standard biphasic and monophasic pacing pulses

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Washington University School of Medicine

    collaborator OTHER

  • Cardialen, Inc.

    lead INDUSTRY

Principal Investigators

  • Daniel H. Cooper, MD · Washington University School of Medicine

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-08
Primary Completion
2022-10-01
Completion
2022-10-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03093051 on ClinicalTrials.gov